We wondered whether the lower expression of HLA-DP in gastric cancer was because of the poor prevalence of EBV among gastric cancer patients since EBV-associated gastric cancer comprises less than 10% of all gastric carcinomas worldwide (50). This evidence concerns the gene HLA-DPA1 and gastric cancer.